Parallax Volatility Advisers, L.P. Amicus Therapeutics, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $91,770 - $124,320	-10,500 Reduced 52.5%	9,500 $90,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $1.41 Million - $2.61 Million	-105,000 Reduced 84.0%	20,000 $462,000
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $1.01 Million - $1.32 Million	91,900 Added 277.64%	125,000 $1.56 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $93,960 - $133,974	8,100 Added 32.4%	33,100 $400,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $3.22 Million - $4.19 Million	-245,000 Reduced 90.74%	25,000 $391,000
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $137,600 - $171,200	-10,000 Reduced 3.57%	270,000 $4.06 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $3.29 Million - $4.42 Million	280,000	280,000 $4.22 Million

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.68B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.